Perivascular mesenchymal cells control adipose-tissue macrophage accrual in obesity

Bo Shan1, Mengle Shao1, Qianbin Zhang1

  • 1Touchstone Diabetes Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Nature Metabolism
|November 3, 2020
PubMed

Insights

Fibro-inflammatory progenitors (FIPs) in white adipose tissue (WAT) drive obesity-related inflammation. Zinc-finger protein 423 (ZFP423) acts as a brake on this inflammation by inhibiting NF-κB signaling.

Area of Science:

  • Cell Biology
  • Metabolic Syndrome Research
  • Immunology

Background:

  • Chronic low-grade inflammation in white adipose tissue (WAT) is a key feature of obesity and metabolic syndrome.
  • Perivascular cells in WAT play a role in metabolic inflammation.

Purpose of the Study:

  • To investigate the role of perivascular cells in WAT inflammation during obesity.
  • To identify molecular mechanisms regulating fibro-inflammatory progenitor (FIP) activation in obesity.
  • To explore the function of zinc-finger protein 423 (ZFP423) in metabolic inflammation.

Main Methods:

  • Utilized mouse models with high-fat diet feeding.
  • Investigated subpopulations of WAT perivascular (PDGFRβ+) cells, termed FIPs.
  • Analyzed the role of ZFP423 as a transcriptional corepressor of NF-κB.
  • Employed doxycycline-inducible expression systems to manipulate ZFP423 levels in PDGFRβ+ cells.

Main Results:

  • FIPs activate proinflammatory signaling and promote macrophage accumulation in WAT in a TLR4-dependent manner.
  • ZFP423 downregulation mediates FIP activation in obesity by enabling NF-κB p65 subunit activity.
  • ZFP423 suppresses NF-κB by inducing a p300-to-NuRD coregulator switch.
  • Inducible ZFP423 expression in FIPs attenuates WAT inflammation, while its inactivation exacerbates it.

Conclusions:

  • Perivascular mesenchymal cells are critical regulators of adipose tissue inflammation in obesity.
  • ZFP423 acts as a crucial transcriptional brake on NF-κB signaling, controlling FIP activity and metabolic inflammation.